AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Nyglim-MV 1 Tablet ER

Prescription Icon
Prescription Required

Marketer

Nysus Biotech

Salt Composition

Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Nyglim-MV 1 Tablet ER

Glucovance XR, a single-strength extended-release tablet, is classified as an antidiabetic medication. This combination therapy manages type 2 diabetes in adults by regulating blood glucose. Administer Glucovance XR with food, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical supervision risks elevated glucose, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan encompassing a healthy diet, regular physical activity, and weight management as directed by your doctor. Lifestyle significantly influences diabetes control. Hypoglycemia (low blood sugar) is a common side effect; learn to identify symptoms like sweating, dizziness, headache, and tremors, and know how to treat them. Maintain regular meals and carry a fast-acting glucose source (e.g., sugary snacks, fruit juice). Alcohol consumption should be limited due to increased hypoglycemia risk. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, swelling, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver impairment. Disclose any history of heart disease to your physician before starting treatment. Pregnant or breastfeeding individuals should seek medical counsel prior to use. Regular blood glucose monitoring, along with blood tests to assess blood cell counts and liver function, are recommended by your physician.

Primary Ingredients of Nyglim-MV 1 Tablet ER

The provided text is "undefined," which offers no content to rephrase. Therefore, no rewritten text can be provided.

Uses of Nyglim-MV 1 Tablet ER

Managing type 2 diabetes

Major Benefits of Nyglim-MV 1 Tablet ER:

Administer this medication precisely as prescribed by your physician, adhering to the recommended dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing. Consume Nyglim-MV 1 Tablet ER on an empty stomach.

Common Side effects of Nyglim-MV 1 Tablet ER:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Nyglim-MV 1 Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet; do not chew, crush, or divide it. Administer Nyglim-MV 1 Extended Release tablet on an empty stomach.

How Nyglim-MV 1 Tablet ER works:

Extended-release Nyglim-MV, a single tablet formulation, contains a triple-action blend of antidiabetic medications.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Nyglim-MV 1 Tablet ER and alcohol is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Nyglim-MV 1mg tablet may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. Prescribing decisions will consider potential benefits against these risks. Physician consultation is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Nyglim-MV tablets (1mg) likely pose a breastfeeding risk. Available human data indicates potential transfer to breast milk, possibly harming the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar abnormalities.

KidneyKidneyUNSAFE

Employing Nyglim-MV 1 Tablet ER is likely inadvisable for individuals with kidney impairment and should be forgone. Physician consultation is recommended. Furthermore, its use is discouraged in patients exhibiting severe kidney dysfunction.

LiverLiverCAUTION

Exercise caution when prescribing Nyglim-MV 1 Tablet ER to individuals with hepatic impairment. Dosage modification may be necessary. Physician consultation is advised. A reduced initial dose is typically recommended for patients exhibiting mild to moderate liver dysfunction; its administration is contraindicated in cases of severe liver disease.

What if you forget to take Nyglim-MV 1 Tablet ER :

Should you forget to take a Nyglim-MV 1 Tablet ER, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Nyglim-MV 1 Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Nyglim-MV 1 Tablet ER

Nyglim-MV 1 Tablet ER combines glimepiride, metformin, and voglibose to manage type 2 diabetes mellitus in adults. This triple-drug therapy improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas; metformin reduces liver glucose production and enhances insulin sensitivity; and voglibose, an alpha-glucosidase inhibitor, lowers postprandial glucose. This combination is unsuitable for type 1 diabetes.
Nyglim-MV 1 Tablet ER may cause common side effects including low blood sugar (hypoglycemia), nausea, diarrhea, altered taste perception, gas, stomach pain, headache, skin rash, and respiratory infection.
Nyglim-MV 1 Tablet ER is contraindicated in patients with known allergies to its components or excipients, those with moderate to severe kidney disease, and those with inflammatory bowel disease, colonic ulcerations, or underlying metabolic acidosis (including diabetic ketoacidosis).
Combining Nyglim-MV 1 Tablet ER and alcohol is unsafe. This combination can worsen low blood sugar and raise the risk of lactic acidosis.
Nyglim-MV 1 Tablet ER can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication properly and keep it out of reach of children, pets, and others.
Nyglim-MV 1 Tablet ER
160
MRP 195
17% off